Skip to main content

Home/ Medicine & Healthcare/ Group items tagged skin-cancer trials BCC

Rss Feed Group items tagged

Filter: All | Bookmarks | Topics Simple Middle
avivajazz jazzaviva

Recurrence rate of superficial basal cell carcinom... [Eur J Dermatol. 2005 Sep-Oct] - ... - 0 views

www.ncbi.nlm.nih.gov/...16172048

recurrence rate recurrences recurrence-rate BCC sBCC basal-cell-carcinoma basalcellcarcinoma treatment treatments skincancer skin-cancer therapy pubmed pubs trials clinicaltrials abstracts therapies imiquimod aldera aldara study studies

shared by avivajazz jazzaviva on 24 Jul 11 - No Cached
  • avivajazz jazzaviva on 24 Jul 11
     
    The initial sBCC clearance rate was 90% (12-week post treatment), whereas the proportion of subjects who were clinically clear at 2 years (current time point) was estimated to be 79.4%.
avivajazz jazzaviva

Superficial basal cell carcinoma treated with imiquimod 5% topical cream for a 4-week p... - 0 views

www.ncbi.nlm.nih.gov/...19646136

BCC sBCC basal-cell-carcinoma basalcellcarcinoma treatment treatments skincancer skin-cancer therapy pubmed pubs trials clinicaltrials abstracts therapies imiquimod aldera aldara study studies 1-year 2-year followup

shared by avivajazz jazzaviva on 24 Jul 11 - No Cached
  • avivajazz jazzaviva on 24 Jul 11
     
    Clinical clearance rate at 1 and 2 years were 89% and 85%, respectively.
‹ Previous 21 - 25 of 25
Showing 20▼ items per page